ZA725037B - Improvements relating to cholesterol-decreasing agents - Google Patents

Improvements relating to cholesterol-decreasing agents

Info

Publication number
ZA725037B
ZA725037B ZA725037A ZA725037A ZA725037B ZA 725037 B ZA725037 B ZA 725037B ZA 725037 A ZA725037 A ZA 725037A ZA 725037 A ZA725037 A ZA 725037A ZA 725037 B ZA725037 B ZA 725037B
Authority
ZA
South Africa
Prior art keywords
cholesterol
improvements relating
decreasing agents
decreasing
agents
Prior art date
Application number
ZA725037A
Other languages
English (en)
Inventor
A Mentrup
H Stoetzer
J Guenard
E Renth
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of ZA725037B publication Critical patent/ZA725037B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/56Radicals substituted by sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58Radicals substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA725037A 1971-07-23 1972-07-21 Improvements relating to cholesterol-decreasing agents ZA725037B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2136929A DE2136929C3 (de) 1971-07-23 1971-07-23 Verwendung bestimmter 3',4'-Methylendioxiphenylpiperazine

Publications (1)

Publication Number Publication Date
ZA725037B true ZA725037B (en) 1974-03-27

Family

ID=5814649

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA725037A ZA725037B (en) 1971-07-23 1972-07-21 Improvements relating to cholesterol-decreasing agents

Country Status (10)

Country Link
AU (1) AU469760B2 (xx)
BE (1) BE786578A (xx)
CA (1) CA991079A (xx)
DE (1) DE2136929C3 (xx)
FR (1) FR2147096B1 (xx)
GB (1) GB1390806A (xx)
IE (1) IE36586B1 (xx)
IL (1) IL39964A (xx)
NL (1) NL7210147A (xx)
ZA (1) ZA725037B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4684651A (en) * 1981-03-17 1987-08-04 Mitsubishi Chemical Industries Limited Alkylenedioxybenzene and acid addition salts thereof useful as hypotensives

Also Published As

Publication number Publication date
NL7210147A (xx) 1973-01-25
AU4486572A (en) 1974-01-24
BE786578A (fr) 1973-01-22
IE36586L (en) 1973-01-23
GB1390806A (en) 1975-04-16
IL39964A0 (en) 1972-09-28
DE2136929B2 (de) 1980-02-07
DE2136929C3 (de) 1980-10-02
AU469760B2 (en) 1976-02-26
DE2136929A1 (de) 1973-02-08
IE36586B1 (en) 1976-12-08
FR2147096B1 (xx) 1976-03-05
CA991079A (en) 1976-06-15
FR2147096A1 (xx) 1973-03-09
IL39964A (en) 1975-08-31

Similar Documents

Publication Publication Date Title
IE36891L (en) Coronary-dilating composition
AU5119173A (en) Composition
HK47978A (en) Improvements relating to scaffolding
ZA728584B (en) Improvements relating to containers
CY783A (en) Improvements relating to fastening devices
ZA722177B (en) Improvements relating to sulphamides
ZA721072B (en) Improvements relating to n-(furyl-methyl)-morphinanes
ZA721238B (en) Improvements relating to seats
ZA715393B (en) Improvements relating to azepine-derivatives
ZA723457B (en) Improvements relating to reconstituted-tobaccosmoking materials
SG8179G (en) Improvements in or relating to thienobenzazepines
ZA712788B (en) Improvements relating to phenylaminoalkanes
ZA716643B (en) Improvements relating to 1-phenoxy-2-hydroxy-3-hydroxyalkylaminopropanes
ZA724206B (en) Improvements relating to crane-head beams
ZA72209B (en) Improvements relating to briefs
ZA723068B (en) Improvements in or relating to wellpoints
ZA723840B (en) Improvements relating to phenylimidazolidinones
HK48076A (en) Improvements relating to pencils
ZA725037B (en) Improvements relating to cholesterol-decreasing agents
ZA71225B (en) Improvements relating to cardenoliderhamnosides
ZA722161B (en) Improvements relating to 4-hydroxy-1-phenyl-2-pyrrolidino-pentane
ZA729073B (en) Improvements relating to benzodiazepines
ZA728201B (en) Improvements relating to castors
ZA728281B (en) Improvements relating to penicillin acylace
YU282572A (en) Kuciste i poklopac kucista